Magnetic Drug Targeting Reduces the Chemotherapeutic Burden on Circulating Leukocytes

Magnetic drug targeting (MDT) improves the integrity of healthy tissues and cells during treatment with cytotoxic drugs. An anticancer drug is bound to superparamagnetic iron oxide nanoparticles (SPION), injected into the vascular supply of the tumor and directed into the tumor by means of an extern...

Descripción completa

Detalles Bibliográficos
Autores principales: Janko, Christina, Dürr, Stephan, Munoz, Luis E., Lyer, Stefan, Chaurio, Ricardo, Tietze, Rainer, von Löhneysen, Sarah, Schorn, Christine, Herrmann, Martin, Alexiou, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645689/
https://www.ncbi.nlm.nih.gov/pubmed/23549268
http://dx.doi.org/10.3390/ijms14047341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645689/
https://www.ncbi.nlm.nih.gov/pubmed/23549268
http://dx.doi.org/10.3390/ijms14047341

Ejemplares similares